Why the study?
Recurrent pericarditis is rare in children with an established treatment strategy lacking, making prevention of recurrences important for quality of life.
Does colchicine improve symptoms in a child with steroid-resistant recurrent pericarditis?
Does colchicine improve symptoms in a child with steroid-resistant recurrent pericarditis?
Colchicine may be an effective treatment option for steroid-resistant recurrent pericarditis in pediatric patients.
Colchicine may be trialed in refractory pediatric recurrent pericarditis; leaves open need for controlled trials to guide practice.
Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient's quality of life. Although a treatment strategy in pediatric recurrent pericarditis has not yet been established, non-steroidal anti-inflammatory drugs (NSAIDs) are the most common treatment for management of this condition, followed by corticosteroids, colchicine, immunosuppressive agents, immunoglobulins, and interleukin-1 receptor antagonists (e.g. anakinra). Herein, we report a case of recurrent pericarditis with pericardial effusion in a 5-year-old child who presented with fever and epigastric pain. He responded poorly to NSAIDs and corticosteroid therapy, but was successfully treated with colchicine.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: